Search results
SIGN guidelines are produced using a standard methodology that has been equality impact assessed to ensure that these equality aims are addressed in every guideline. This methodology is set out in the current version of SIGN 50, our guideline manual, which can
Quick Reference Guide. July 2017. Evidence. ESTIMATING CARDIOVASCULAR RISK. Individuals with the following risk factors should be considered at high risk of cardiovascular events: established cardiovascular disease, or. stage 3 or higher chronic kidney disease or micro- or macroalbuminuria, or. familial hypercholesterolaemia, or.
The current guideline provides comprehensive advice on prevention and management of VTE based on the evidence available to answer a set of key questions, listed in Annex 1. 1.1.2 EPIDEMIOLOGY OF VENOUS THROMBOEMBOLISM
30 sie 2024 · This 2024 guideline, developed by a multidisciplinary Task Force, updates the 2018 ESC/ESH guidelines on the management of arterial hypertension, using the most robust contemporary evidence.
28 sie 2019 · This guideline covers identifying and treating primary hypertension (high blood pressure) in people aged 18 and over, including people with type 2 diabetes.
The 2020 ISH Global Hypertension Practice Guidelines were developed by the ISH Hypertension Guidelines Committee based on evidence criteria, (1) to be used globally; (2) to be fit for application in low and high resource settings by advis-ing on essential and optimal standards; and (3) to be concise, simplified, and easy to use.
The ESH 2024 Clinical Practice Guidelines provide a novel concise format that supports the dissemination of the most important information of the Guidelines for the management of the general hypertensive population and its implementation into clinical practice.
